| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| review article | Q7318358 |
| P356 | DOI | 10.1002/14651858.CD002244.PUB3 |
| P8608 | Fatcat ID | release_z573lxbwobh5pddkjsvjlpz3pq |
| P3181 | OpenCitations bibliographic resource ID | 665471 |
| P698 | PubMed publication ID | 18254003 |
| P50 | author | Kameshwar Prasad | Q24190663 |
| P2093 | author name string | Mamta B Singh | |
| P2860 | cites work | Systematic reviews in health care: Assessing the quality of controlled clinical trials | Q29618659 |
| Steroids for treating tuberculous meningitis. | Q33978600 | ||
| Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults | Q33982474 | ||
| Management of tuberculosis meningitis | Q37917071 | ||
| The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses | Q39464569 | ||
| Dexamethasone in tuberculous meningitis. Relationship of cerebrospinal fluid effects to therapeutic efficacy | Q43501660 | ||
| Extrapulmonary tuberculosis in the United States | Q43611798 | ||
| Adjunctive steroids for tuberculous meningitis--more evidence, more questions | Q43742324 | ||
| Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis | Q43858728 | ||
| Tuberculous meningitis in patients infected with the human immunodeficiency virus | Q45008897 | ||
| Randomized controlled trial of dexamethasone in tuberculous meningitis. | Q52026153 | ||
| Dexamethasone for Tuberculous Meningitis | Q59424586 | ||
| Tuberculous meningitis. Short course of chemotherapy | Q68622265 | ||
| Three chemotherapy studies of tuberculous meningitis in children | Q69531987 | ||
| Dexamethasone adjunctive treatment for tuberculous meningitis | Q70171785 | ||
| The use of dexamethasone in preventing ocular complications in tuberculous meningitis | Q71157405 | ||
| Evaluation of intrathecal therapy with streptomycin and hydrocortisone in tuberculous meningitis | Q71564657 | ||
| Corticosteroids as an adjuvant to the chemotherapy of tuberculous meningitis | Q72847068 | ||
| THE CHANGING INCIDENCE AND PROGNOSIS OF TUBERCULOUS MENINGITIS | Q78424397 | ||
| The present status of the treatment of tuberculosis of the central nervous system | Q79441139 | ||
| Tuberculous meningitis | Q80889424 | ||
| P921 | main subject | meningitis | Q48143 |
| tuberculous meningitis | Q3854687 | ||
| P577 | publication date | 2008-01-23 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Corticosteroids for managing tuberculous meningitis |
| Q30151881 | 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis |
| Q38130446 | A 43-year systematic review and meta-analysis: case-fatality and risk of death among adults with tuberculous meningitis in Africa |
| Q42123841 | A Case of Tuberculous Meningitis with Tuberculoma in Nonimmunocompromised Immigrant |
| Q33780044 | A case of Pott's disease with epidural abscess and probable cerebral tuberculoma following Bacillus Calmette-Guérin therapy for superficial bladder cancer |
| Q57496816 | Adjunctive dexamethasone for the treatment of HIV-infected adults with tuberculous meningitis (ACT HIV): Study protocol for a randomised controlled trial |
| Q24188019 | Adjunctive steroid therapy for managing pulmonary tuberculosis |
| Q58104067 | An Infant with Xpert Confirmed TB Meningitis in Central Viet Nam |
| Q38878123 | Antimycobacterial and anti-inflammatory activities of substituted chalcones focusing on an anti-tuberculosis dual treatment approach. |
| Q83393622 | Approach to the diagnosis and management of tuberculous meningitis |
| Q36238031 | B cells and antibodies in the defense against Mycobacterium tuberculosis infection |
| Q86646236 | Bacterial infections of the central nervous system |
| Q94563545 | Calculated parenteral initial therapy of bacterial infections: Bacterial meningitis |
| Q56888037 | Central Nervous System Tuberculosis : Etiology, Clinical Manifestations and Neuroradiological Features |
| Q45969852 | Central Nervous System Tuberculosis: Challenges and Advances in Diagnosis and Treatment. |
| Q42279526 | Central nervous system Tuberculosis in a man from Cambodia with worsening headaches |
| Q28237650 | Central nervous system tuberculosis |
| Q38737982 | Chronic Meningitis: Simplifying a Diagnostic Challenge |
| Q54256360 | Coccidioidal Meningitis: A Review on Diagnosis, Treatment, and Management of Complications. |
| Q42268644 | Computational modeling of tuberculous meningitis reveals an important role for tumor necrosis factor-α. |
| Q24186045 | Corticosteroids as adjunctive therapy in the treatment of influenza |
| Q24201063 | Corticosteroids as adjunctive therapy in the treatment of influenza |
| Q24185853 | Corticosteroids for managing tuberculous meningitis |
| Q34102881 | Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents |
| Q35307259 | Diagnosis and treatment of extrapulmonary tuberculosis |
| Q38068542 | Disseminated tuberculosis and tuberculous meningitis in Australian-born children; case reports and review of current epidemiology and management. |
| Q85166985 | Do corticosteroids improve outcome in meningitis? |
| Q33801345 | Drug-resistant tuberculosis and advances in the treatment of childhood tuberculosis |
| Q84830501 | Drug-resistant tuberculosis in two children in Greece: report of the first extensively drug-resistant case |
| Q34418500 | Evaluation and treatment of chronic meningitis |
| Q40542672 | Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. |
| Q35603012 | Extensive infectious myelitis post bariatric surgery |
| Q38679578 | Fever of unknown origin in a Swiss-born child: don't miss tuberculosis! |
| Q58770575 | Functional outcomes in adults with tuberculous meningitis admitted to the ICU: a multicenter cohort study |
| Q35779173 | GeneXpert MTB/RIF assay as initial test for diagnosis of tuberculous meningitis |
| Q51762497 | Global HIV neurology: a comprehensive review. |
| Q37794462 | HIV-associated tuberculous meningitis--diagnostic and therapeutic challenges. |
| Q42323040 | Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections |
| Q45006012 | Host-Directed Therapeutic Strategies for Tuberculosis |
| Q38489473 | Host-Directed Therapies for Tuberculosis. |
| Q54857369 | How to manage TB in children? Problems and solutions in four cases. |
| Q26829220 | Immune vulnerability of infants to tuberculosis |
| Q38897214 | Infectious encephalitis: Management without etiological diagnosis 48hours after onset. |
| Q26749428 | Integrated therapy for HIV and tuberculosis |
| Q63367670 | Intensified intravenous rifampicin in tuberculous meningitis |
| Q42026631 | Intrathecal Isoniazid for Refractory Tuberculous Meningitis with Cerebral Infarction |
| Q39523555 | Leukotriene A4 Hydrolase Genotype and HIV Infection Influence Intracerebral Inflammation and Survival From Tuberculous Meningitis |
| Q38094111 | Long-term sequelae of childhood bacterial meningitis |
| Q49584294 | Management challenge: Optic disc granuloma in pulmonary tuberculosis |
| Q37785181 | Management of Acute, Recurrent, and Chronic Meningitides in Adults |
| Q38259519 | Meningitis in HIV-positive patients in sub-Saharan Africa: a review |
| Q37545421 | Microglia activation in a pediatric rabbit model of tuberculous meningitis |
| Q34081782 | Modeling tuberculous meningitis in zebrafish using Mycobacterium marinum. |
| Q36125477 | Multiple ring-enhancing cerebral lesions in systemic lupus erythematosis: a case report. |
| Q37779049 | Neurologic consequences of the immune reconstitution inflammatory syndrome (IRIS). |
| Q38922815 | Nitric Oxide Production Inhibition and Anti-Mycobacterial Activity of Extracts and Halogenated Sesquiterpenes from the Brazilian Red Alga Laurencia Dendroidea J. Agardh |
| Q28079392 | Nonsurgical therapy for hydrocephalus: a comprehensive and critical review |
| Q26829957 | Novel adjunctive therapies for the treatment of tuberculosis |
| Q40578494 | Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. |
| Q28085210 | Recent Developments and Future Opportunities in the Treatment of Tuberculosis in Children |
| Q28481610 | Research questions and priorities for tuberculosis: a survey of published systematic reviews and meta-analyses |
| Q34440066 | Respiratory review of 2014: tuberculosis and nontuberculous mycobacterial pulmonary disease. |
| Q85240155 | Some diseases will come back |
| Q33743408 | Steroids alone or as adjunctive therapy with doxycycline fail to improve oviduct damage in mice infected with Chlamydia muridarum |
| Q52680275 | Treatment of Tuberculous Meningitis and Its Complications in Adults. |
| Q57235679 | Tuberculosis |
| Q35557036 | Tuberculosis of the central nervous system in immunocompromised patients: HIV infection and solid organ transplant recipients |
| Q37558272 | Tuberculous Meningitis in an Immunocompetent Host: A Case Report |
| Q33826837 | Tuberculous meningitis in Denmark: a review of 50 cases |
| Q40084374 | Tuberculous meningitis in an immunocompetent male complicated by hydrocephalus |
| Q42018926 | Tuberculous meningitis: Diagnostic and therapeutic challenges. |
| Q54206218 | Tuberculous meningitis: a roadmap for advancing basic and translational research. |
| Q35910242 | Tuberculous meningitis: diagnosis and treatment overview |
| Q38131175 | Tuberculous meningitis: more questions, still too few answers |
| Q37301031 | Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases |
| Q53759250 | Use of corticosteroids in tuberculous meningitis. |
Search more.